Bright Minds Biosciences Inc.

NASDAQ:DRUG

Biotechnology

Healthcare
$20.76 +1.04%

+$0.62 today

Market cap
$204.78M
Beta
-0.11
P/E (TTM)
-29.8
EPS (TTM)
-$2.87
52W Low $23.18High $123.75

Volume 0.14M

Average 0.27M

DRUG Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Bright Minds Biosciences Inc.NASDAQ: DRUG

Other Income / Expenses · Q2 FY2026 · quarter ended Mar 2026

Other income / expenses growth accelerates

Q2 FY2026 other income / expenses of CA$4.94M rose 1128.6% year over year, ahead of the +87.0% change in trailing-twelve-month other income / expenses. Over 3 fiscal years it compounded at +452.1% a year.

Context

  • Other income / expenses increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1128.6% holds above the trailing-twelve-month pace of +87.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$4.94M+846.4% QoQ
Last fiscal yearSep 2025
CA$1.71M+8104.4% YoY
LTMMar 2026
CA$3.91M+87.0% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1128.6%——
1 year+8104.4%——
3-year CAGR+452.1%——
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

CAD · from the income statement

Latest · FY2025
1.71M CAD
Year-over-year change
+8104.4%

Other Income / Expenses vs competitors

How DRUG compares with its peers on the latest reported figures

No competitor Other Income / Expenses figures are available to compare.

Income Statement

CAD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development6.31M12.18M5M1.18M11.08M
Selling, General & Admin2.31M2.55M2.2M1.45M2.57M
Operating Expenses8.62M14.98M7.39M2.82M13.94M
Depreciation & Amortization8.62M6.04K72.45K73.36K76.87K
EBITDA(27.64K)(14.96M)(7.3M)(2.73M)(12.15M)
EBITDA Margin—————
Operating Income(8.62M)(14.98M)(7.39M)(2.82M)(13.94M)
Operating Margin—————
Interest Income00030.13K1.52M
Interest Expense00000
Other Income / Expenses(27.64K)10.15K14.19K20.82K1.71M
Income Before Tax(8.65M)(14.96M)(7.37M)(2.8M)(12.23M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(8.65M)(14.96M)(7.37M)(2.8M)(12.23M)
Net Margin—————
EPS (Basic)(4.74)(6.15)(1.98)(0.65)(1.78)
EPS (Diluted)(4.74)(6.15)(1.98)(0.65)(1.78)
Weighted Avg Shares1.79M2.47M3.72M4.31M6.88M
Weighted Avg Shares (Diluted)1.79M2.47M3.72M4.31M6.88M

Bright Minds Biosciences Inc.

NASDAQ:DRUG

Intrinsic Alpha fair value

Locked

Current Price

$20.76

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.